Your browser doesn't support javascript.
Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel.
Swift, Melanie D; Breeher, Laura E; Tande, Aaron J; Tommaso, Christopher P; Hainy, Caitlin M; Chu, Haitao; Murad, M Hassan; Berbari, Elie F; Virk, Abinash.
  • Swift MD; Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Breeher LE; Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Tande AJ; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.
  • Tommaso CP; Occupational Health Services, Mayo Clinic, Rochester, Minnesota, USA.
  • Hainy CM; Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Chu H; Division of Biostatistics, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA.
  • Murad MH; Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Berbari EF; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.
  • Virk A; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Clin Infect Dis ; 73(6): e1376-e1379, 2021 09 15.
Article in English | MEDLINE | ID: covidwho-1413850
ABSTRACT
In a large cohort of United States healthcare personnel without prior coronavirus disease 2019 (COVID-19) infection, 94 382 doses of messenger RNA (mRNA) COVID-19 vaccine were administered to 49 220 individuals. The adjusted vaccine effectiveness following 2 doses of each of the 2 available brands of mRNA vaccine exceeded 96%.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid